— Ticker · NYQ —
ABBV · AbbVie Inc.
Healthcare · Drug Manufacturers - General
ABBV
$213.12
▲ +1.11%
7-day move
7-day move
day$211.91 → $217.0552-wk$181.73 → $244.81avg vol6.8M / 3Mcap$376.5B
Plate I.
The Past Year, in One Line
The Valuation
| P/E (forward) | 13.1 |
| P/E (trailing) | 104.0 |
| EPS (forward) | $16.23 |
| EPS (trailing) | $2.05 |
| PEG | 0.59 |
| Dividend | 3.21% |
The Risk
| Beta | 0.30 |
| Short % float | 1.32% |
| Float | 1.76B |
| Shares out | 1.77B |
| Avg vol (3M) | 6.8M |
| 52w range | $181.73 → $244.81 |
The Analyst Tape
strong buybuyholdunderperformsell
$252.90
avg 12-mo target
+18.7%
vs. last · 29 analysts
At a Glance
$376.5B
market cap (USD)
exchangeNYQ
sectorHealthcare
industryDrug Manufacturers - General
market cap$376.5B
websiteabbvie.com
The Briefs
live, polled every 60 seconds · Alpaca / Benzinga
No recent headlines for ABBV in the last 7 days.
Word on the Street
StockTwits public feed · self-tagged bull/bear
No recent StockTwits posts for ABBV.
Indicators That Mention ABBV
2 of our 596 catalog map to ABBV
SP-1090
AbbVie
Pharma mega-cap. Production tell via epa_abbv_waste.
49%
49%
49%
49%
↓52%
48%
●Still works on fresh data
r=-0.10
SP-3349
ABBV TRI Chemical Releases
Annual chemical releases from AbbVie US plants. Pharma batch chemistry.
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
Standard Poorly Disclaimer
We tested 297 indicators against four horizons. By chance alone, ~59 of these correlations should look "significant." Walk-forward out-of-sample is the only thing we trust. This one too new to retest.Other Players in the Pipeline
Healthcare · by market cap · 7-day move